Acorah Software Products - Accounts Production 16.3.350 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 12507446 Dr David Taussig iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12507446 2024-03-31 12507446 2025-03-31 12507446 2024-04-01 2025-03-31 12507446 frs-core:CurrentFinancialInstruments 2025-03-31 12507446 frs-core:ShareCapital 2025-03-31 12507446 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 12507446 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12507446 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 12507446 frs-bus:SmallEntities 2024-04-01 2025-03-31 12507446 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12507446 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12507446 frs-core:ListedExchangeTraded 2025-03-31 12507446 frs-core:ListedExchangeTraded 2024-03-31 12507446 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-03-31 12507446 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2025-03-31 12507446 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-03-31 12507446 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-03-31 12507446 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-03-31 12507446 frs-bus:Director1 2024-04-01 2025-03-31 12507446 frs-countries:EnglandWales 2024-04-01 2025-03-31 12507446 2023-03-31 12507446 2024-03-31 12507446 2023-04-01 2024-03-31 12507446 frs-core:CurrentFinancialInstruments 2024-03-31 12507446 frs-core:ShareCapital 2024-03-31 12507446 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 12507446
Leukaemia Management Ltd
Financial Statements
For The Year Ended 31 March 2025
AJN Accountants Limited
Hideaway Workspace
1 Empire Mews
Streatham
SW16 2BF
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 12507446
2025 2024
Notes £ £ £ £
FIXED ASSETS
Investments 4 120,294 -
120,294 -
CURRENT ASSETS
Cash at bank and in hand 58,790 102,801
58,790 102,801
Creditors: Amounts Falling Due Within One Year 5 (22,431 ) (15,085 )
NET CURRENT ASSETS (LIABILITIES) 36,359 87,716
TOTAL ASSETS LESS CURRENT LIABILITIES 156,653 87,716
NET ASSETS 156,653 87,716
CAPITAL AND RESERVES
Called up share capital 6 100 100
Profit and Loss Account 156,553 87,616
SHAREHOLDERS' FUNDS 156,653 87,716
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr David Taussig
Director
25/04/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Leukaemia Management Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12507446 . The registered office is C/O Ajn Accountants 1 Empire Mews, Streatham, London, SW16 2BF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

The financial statements are presented in £ Sterling.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Investments
Listed
£
Cost
As at 1 April 2024 -
Additions 120,294
As at 31 March 2025 120,294
Provision
As at 1 April 2024 -
As at 31 March 2025 -
...CONTINUED
Page 2
Page 3
Net Book Value
As at 31 March 2025 120,294
As at 1 April 2024 -
5. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors (1 ) -
Corporation tax 19,753 13,018
Accruals and deferred income 900 900
Director's loan account 1,779 1,167
22,431 15,085
6. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
Page 3